Center For Asset Management’s United Therapeutics UTHR Stock Holding History

Center For Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Buy	2,911 +55	+2%	+$31K	0.7%	43
2026 Q1	$1.69M	Buy	2,856 +3	+0.1%	+$1.49K	0.84%	36
2025 Q4	$1.39M	Sell	2,853 -244	-8%	-$114K	0.73%	40
2025 Q3	$1.3M	Buy	3,097 +1,446	+88%	+$486K	0.69%	38
2025 Q2	$590K	Buy	1,651 +17	+1%	+$5.08K	0.36%	57
2025 Q1	$504K	Sell	1,634 -52	-3%	-$17.8K	0.31%	69
2024 Q4	$595K	Buy	1,686 +73	+5%	+$26.8K	0.39%	53
2024 Q3	$578K	Buy	+1,613	New	+$545K	0.35%	67

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Center For Asset Management's UTHR Position: Q2 2026 in Review

Center For Asset Management increased its United Therapeutics (UTHR) stake by 1.9% in Q2 2026, buying an estimated $31K and bringing the position to 2,911 shares worth $1.58M. The position accounts for 0.7% of the portfolio, ranked #43.

Center For Asset Management first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.69M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Center For Asset Management held 2,911 shares of United Therapeutics worth $1.58M as of Q2 2026.
Center For Asset Management bought 55 United Therapeutics shares in Q2 2026, an estimated $31K.
United Therapeutics made up 0.7% of Center For Asset Management's portfolio in Q2 2026, its #43 holding.
Center For Asset Management first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
Center For Asset Management's United Therapeutics position peaked at $1.69M in Q1 2026.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Center For Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.